Skip to content

Clinical trials

Completed Phase 1/2 Lymphoma, T-Cell trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, T-Cell Phase: Phase 1/2 Status: Completed Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20091
20102
20111
20121
20132
20152
20172
20191
20201
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center2
National Cancer Institute (NCI)2
Acrotech Biopharma Inc.1
Ahmed Sawas1
Alexion Pharmaceuticals, Inc.1
CRISPR Therapeutics1
Fred Hutchinson Cancer Center1
Kyowa Kirin Co., Ltd.1
Mayo Clinic1
Memorial Sloan Kettering Cancer Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, T-Cell15
Lymphoma, B-Cell6
Hodgkin Disease5
Lymphoma, Large-Cell, Anaplastic5
Immunoblastic Lymphadenopathy4
Lymphoma, Follicular4
Lymphoma, Non-Hodgkin4
Lymphoma, T-Cell, Cutaneous4
Leukemia3
Leukemia, Lymphocytic, Chronic, B-Cell3

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.